ConvaTec Receives Growth Strategy Leadership Award

Monday, December 22, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

Frost & Sullivan Applauds ConvaTec For Breakthrough Innovations In Advanced Wound Management

SKILLMAN, N.J., Dec. 22 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has received the Frost & Sullivan 2008 North American Growth Strategy Leadership Award for the advanced wound management market. This award, presented to the company that has demonstrated an exceptional long-term growth strategy within its own industry, was bestowed at the annual 2008 Excellence in Healthcare Awards Banquet in San Antonio, Texas.

In making the award, Frost & Sullivan commended ConvaTec for its product innovations and strong brands, as well as support and collaboration with wound care specialists.

"With the development of innovative and technologically advanced wound care products, ConvaTec is securing a strong reputation as a valuable partner that provides comprehensive solutions to meet the evolving demands of its customers," said Frost & Sullivan Research Analyst Sheila Ewing. "By leveraging the widespread success of the highly versatile, efficient and cost-effective dressings, we expect ConvaTec will continue to be a leader in the advanced wound care market."

ConvaTec innovations have redefined wound management and patient care, beginning with the introduction of DuoDERM(R) Hydroactive(R) dressing, the original hydrocolloid dressing that ushered in a new era of moist wound healing. ConvaTec has built on this strong heritage with its Hydrofiber(R) Technology, featured in advanced wound dressings such as AQUACEL(R), an absorbent, soft, conformable dressing which forms a cool gelling sheet on contact with exudate; and AQUACEL(R) Ag, an antimicrobial dressing with ionic silver. In addition, Versiva(R) XC(TM) is a next generation "gelling foam" dressing that combines the superior fluid absorption and retention of Hydrofiber(R) with the cushioning comfort of foam.

"ConvaTec is honored to be recognized by Frost & Sullivan as the 2008 North American Advanced Wound Management Growth Strategy Leader," said Michael E. Steadman, President, Wound Therapeutics, ConvaTec. "As a global market leader in three of four advanced wound care categories, we at ConvaTec are extremely proud of this recognition and are committed to continuing to develop cutting-edge products and technologies that improve patient outcomes."

The Frost & Sullivan 2008 Growth Strategy Leadership Award is presented annually to the company that has bolstered its position in the market, and whose strategy will have a lasting impact on the market. This award signifies the company's ability to grow in a saturated or maturing market, implement a unique sales strategy and discover new sales avenues for an established product. Moreover, this award also recognizes that the company has successfully reorganized their structure around growth strategy.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit

(C) 2008 ConvaTec Inc.

AQUACEL, AQUACEL Ag, Hydrofiber, DuoDERM Hydroactive and Versiva are registered trademarks of ConvaTec Inc.

XC is a trademark of ConvaTec Inc.


Contacts Punnie Donohue Nimisha Savani Weber Shandwick ConvaTec Phone: 212-445-8163 Phone: 908-904-2522


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store